News

PFE eyes Q2 earnings beat as strength in Vyndaqel and Padcev is expected to offset declines from Eliquis, Ibrance and Prevnar ...
Amazon's $4B stake in Anthropic and deep AWS integration boost enterprise AI adoption. Click here to find out how Claude ...
Eli Lilly › Great businesses have a habit of remaining so even when market volatility arises. The stock market is cyclical, ...
Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) ('Ascentage Pharma” or the 'Company”), a global biopharmaceutical company dedicated to addressing unmet medical needs in cancers, ...
A stellar launch of the rare heart disease med Amvuttra has boosted Alnylam’s market cap above $50 billion. | A stellar launch of Amvuttra in the rare heart disease ATTR-CM has boosted Alnylam’s ...
Former Google CEO Eric Schmidt was among Anthropic’s first investors. He’d met Amodei through his then-girlfriend and now ...
Ligand to invest $35 million in exchange for a tiered royalty on future sales of Orchestra's AVIM therapy and Virtue SAB and an additional $5 million in an equity private placement • Medtronic to inve ...
We profile four of the finalists chosen in the emerging category for this year’s EY Entrepreneur of the Year awards ...
In the most recent trading session, Pfizer (PFE) closed at $23.27, indicating a -2.29% shift from the previous trading day.
Ligand to invest $35 million in exchange for a tiered royalty on future sales of Orchestra’s AVIM therapy and Virtue SAB and an additional $5 million in an equity private placement ...
Alnylam Pharmaceuticals, Inc. shares soar with strong Q2 results, driven by Amvuttra's stellar U.S. launch for ATTR ...
Pfizer Inc ( (PFE) ), Astellas Pharma ( (ALPMF) ), Astellas Pharma ( (ALPMY)) announced an update on their ongoing clinical study.